Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders

NCT05134584 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Functional Dyspepsia
Constipation-predominant Irritable Bowel Syndrome

Interventions

DRUG: Linaclotide
DRUG: Lactulose
DRUG: Omeprazol
DRUG: Itopride

Sponsor

RenJi Hospital